Chief Executive Officer, FUJIFILM Diosynth Biotechnologies
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets.
Martin was named Chief Executive Officer on April 1st, 2020, after serving as Chief Operating Officer and President of our US FDB operations (North Carolina and Texas). Previously Martin served as Chief Financial Officer for the US. Prior to this, Martin worked for FUJIFILM Diosynth Biotechnologies for over 6 years, holding leadership positions at the United Kingdom site, including Head of Finance and IT. Before joining FUJIFILM Diosynth Biotechnologies, he was Finance Director at Oxford Chemicals where he was responsible for all aspects of Finance, IT, and Purchasing. He also held leadership positions at Hibernia Foods, ICI/Dupont and KPMG.